Latest Parkinson's Stories
Supports Partnerships Between Patient Advocates and Scientists at Four Leading Parkinson's Research Centers NEW YORK, March 28, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease
VALLEY VIEW, Ohio, March 5, 2014 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S.
NEW YORK, Feb. 25, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Progression Markers Initiative (PPMI), a large-scale biomarker study sponsored by The Michael J.
Third Phase of Collaboration Aims to Unravel Mysteries of Disease by Identifying Disease Markers and Potential New Drug Targets FRAMINGHAM, Mass. and SUNNYVALE, Calif., Feb.
Mounting Evidence of Biological Similarities Inspires Funding Program to Advance Understanding of Two Most Common Brain Diseases CHICAGO, NEW YORK and TORONTO, Feb.
VALLEY VIEW, Ohio, Feb. 4, 2014 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office.
Alliance Leverages Independent Nonprofit Strengths to Enrich Programs for Parkinson's Community NEW YORK, Jan.
- A trick or prank.